| UniProt ID | PI3R4_HUMAN | |
|---|---|---|
| UniProt AC | Q99570 | |
| Protein Name | Phosphoinositide 3-kinase regulatory subunit 4 | |
| Gene Name | PIK3R4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1358 | |
| Subcellular Localization |
Late endosome . Cytoplasmic vesicle, autophagosome . Membrane Lipid-anchor . As component of the PI3K complex I localized to pre-autophagosome structures. As component of the PI3K complex II localized predominantly to endosomes. Localizes also to d |
|
| Protein Description | Regulatory subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of autophagosomes and endocytosis. Involved in regulation of degradative endocytic trafficking and cytokinesis, probably in the context of PI3KC3-C2. [PubMed: 20643123] | |
| Protein Sequence | MGNQLAGIAPSQILSVESYFSDIHDFEYDKSLGSTRFFKVARAKHREGLVVVKVFAIQDPTLPLTSYKQELEELKIRLNSAQNCLPFQKASEKASEKAAMLFRQYVRDNLYDRISTRPFLNNIEKRWIAFQILTAVDQAHKSGVRHGDIKTENVMVTSWNWVLLTDFASFKPTYLPEDNPADFNYFFDTSRRRTCYIAPERFVDGGMFATELEYMRDPSTPLVDLNSNQRTRGELKRAMDIFSAGCVIAELFTEGVPLFDLSQLLAYRNGHFFPEQVLNKIEDHSIRELVTQMIHREPDKRLEAEDYLKQQRGNAFPEIFYTFLQPYMAQFAKETFLSADERILVIRKDLGNIIHNLCGHDLPEKAEGEPKENGLVILVSVITSCLQTLKYCDSKLAALELILHLAPRLSVEILLDRITPYLLHFSNDSVPRVRAEALRTLTKVLALVKEVPRNDINIYPEYILPGIAHLAQDDATIVRLAYAENIALLAETALRFLELVQLKNLNMENDPNNEEIDEVTHPNGNYDTELQALHEMVQQKVVTLLSDPENIVKQTLMENGITRLCVFFGRQKANDVLLSHMITFLNDKNDWHLRGAFFDSIVGVAAYVGWQSSSILKPLLQQGLSDAEEFVIVKALYALTCMCQLGLLQKPHVYEFASDIAPFLCHPNLWIRYGAVGFITVVARQISTADVYCKLMPYLDPYITQPIIQIERKLVLLSVLKEPVSRSIFDYALRSKDITSLFRHLHMRQKKRNGSLPDCPPPEDPAIAQLLKKLLSQGMTEEEEDKLLALKDFMMKSNKAKANIVDQSHLHDSSQKGVIDLAALGITGRQVDLVKTKQEPDDKRARKHVKQDSNVNEEWKSMFGSLDPPNMPQALPKGSDQEVIQTGKPPRSESSAGICVPLSTSSQVPEVTTVQNKKPVIPVLSSTILPSTYQIRITTCKTELQQLIQQKREQCNAERIAKQMMENAEWESKPPPPGWRPKGLLVAHLHEHKSAVNRIRVSDEHSLFATCSNDGTVKIWNSQKMEGKTTTTRSILTYSRIGGRVKTLTFCQGSHYLAIASDNGAVQLLGIEASKLPKSPKIHPLQSRILDQKEDGCVVDMHHFNSGAQSVLAYATVNGSLVGWDLRSSSNAWTLKHDLKSGLITSFAVDIHQCWLCIGTSSGTMACWDMRFQLPISSHCHPSRARIRRLSMHPLYQSWVIAAVQGNNEVSMWDMETGDRRFTLWASSAPPLSELQPSPHSVHGIYCSPADGNPILLTAGSDMKIRFWDLAYPERSYVVAGSTSSPSVSYYRKIIEGTEVVQEIQNKQKVGPSDDTPRRGPESLPVGHHDIITDVATFQTTQGFIVTASRDGIVKVWK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | N-myristoyl glycine | ------MGNQLAGIA ------CCCCCCCCC | 41.73 | - | |
| 2 | Myristoylation | ------MGNQLAGIA ------CCCCCCCCC | 41.73 | 8999962 | |
| 39 | Ubiquitination | LGSTRFFKVARAKHR CCCCCHHHHHHHHCC | 32.07 | 27667366 | |
| 61 | Phosphorylation | VFAIQDPTLPLTSYK EEEECCCCCCCCCHH | 49.66 | 21406692 | |
| 65 | Phosphorylation | QDPTLPLTSYKQELE CCCCCCCCCHHHHHH | 28.24 | 21406692 | |
| 66 | Phosphorylation | DPTLPLTSYKQELEE CCCCCCCCHHHHHHH | 37.71 | 21406692 | |
| 67 | Phosphorylation | PTLPLTSYKQELEEL CCCCCCCHHHHHHHH | 16.08 | 21406692 | |
| 68 | Ubiquitination | TLPLTSYKQELEELK CCCCCCHHHHHHHHH | 36.74 | 21906983 | |
| 75 | Ubiquitination | KQELEELKIRLNSAQ HHHHHHHHHHHHHHC | 29.12 | 27667366 | |
| 89 | Ubiquitination | QNCLPFQKASEKASE CCCCCHHHHHHHHHH | 55.01 | 21963094 | |
| 93 | Ubiquitination | PFQKASEKASEKAAM CHHHHHHHHHHHHHH | 55.51 | 22817900 | |
| 97 | Ubiquitination | ASEKASEKAAMLFRQ HHHHHHHHHHHHHHH | 38.66 | 21906983 | |
| 111 | Phosphorylation | QYVRDNLYDRISTRP HHHHHHHHHHHCCCH | 14.94 | 24043423 | |
| 115 | Phosphorylation | DNLYDRISTRPFLNN HHHHHHHCCCHHHHH | 21.18 | 24043423 | |
| 116 | Phosphorylation | NLYDRISTRPFLNNI HHHHHHCCCHHHHHH | 39.73 | 24043423 | |
| 169 | Phosphorylation | VLLTDFASFKPTYLP EEEECHHHCCCCCCC | 33.52 | 24719451 | |
| 210 | Phosphorylation | VDGGMFATELEYMRD CCCCCCEEHHHCCCC | 29.82 | 28796482 | |
| 214 | Phosphorylation | MFATELEYMRDPSTP CCEEHHHCCCCCCCC | 15.29 | 28796482 | |
| 219 | Phosphorylation | LEYMRDPSTPLVDLN HHCCCCCCCCCCCCC | 47.12 | 28796482 | |
| 220 | Phosphorylation | EYMRDPSTPLVDLNS HCCCCCCCCCCCCCC | 26.48 | 28796482 | |
| 280 | Ubiquitination | FPEQVLNKIEDHSIR CHHHHHHHHCCCCHH | 43.22 | 21906983 | |
| 300 | Ubiquitination | MIHREPDKRLEAEDY HHHCCCCHHHCHHHH | 70.38 | 29967540 | |
| 309 | Ubiquitination | LEAEDYLKQQRGNAF HCHHHHHHHHHCCCC | 37.85 | 21906983 | |
| 338 | Phosphorylation | FAKETFLSADERILV HHHHHHCCCCCEEEE | 29.50 | - | |
| 348 | Ubiquitination | ERILVIRKDLGNIIH CEEEEEECHHHHHHH | 46.29 | 29967540 | |
| 419 | Phosphorylation | EILLDRITPYLLHFS HHHHHHHHHHHHHCC | 13.53 | 29209046 | |
| 421 | Phosphorylation | LLDRITPYLLHFSND HHHHHHHHHHHCCCC | 17.16 | 29209046 | |
| 426 | Phosphorylation | TPYLLHFSNDSVPRV HHHHHHCCCCCCHHH | 29.04 | 29209046 | |
| 429 | Phosphorylation | LLHFSNDSVPRVRAE HHHCCCCCCHHHHHH | 37.97 | 29209046 | |
| 443 | Ubiquitination | EALRTLTKVLALVKE HHHHHHHHHHHHHHC | 38.06 | 21963094 | |
| 449 | Ubiquitination | TKVLALVKEVPRNDI HHHHHHHHCCCCCCC | 54.57 | 21906983 | |
| 459 | Phosphorylation | PRNDINIYPEYILPG CCCCCCCCHHHHCCC | 5.87 | 24043423 | |
| 462 | Phosphorylation | DINIYPEYILPGIAH CCCCCHHHHCCCHHH | 11.85 | 24043423 | |
| 476 | Phosphorylation | HLAQDDATIVRLAYA HHHCCCCHHHHHHHH | 27.31 | 24043423 | |
| 482 | Phosphorylation | ATIVRLAYAENIALL CHHHHHHHHHHHHHH | 21.02 | 24043423 | |
| 492 | Phosphorylation | NIALLAETALRFLEL HHHHHHHHHHHHHHH | 25.94 | 24043423 | |
| 543 | Phosphorylation | MVQQKVVTLLSDPEN HHHHHHHHHHCCHHH | 25.60 | 20068231 | |
| 546 | Phosphorylation | QKVVTLLSDPENIVK HHHHHHHCCHHHHHH | 54.99 | 20068231 | |
| 553 | Ubiquitination | SDPENIVKQTLMENG CCHHHHHHHHHHHCC | 33.49 | 21906983 | |
| 579 | Phosphorylation | KANDVLLSHMITFLN HHHHHHHHHHHHHHC | 13.57 | 26270265 | |
| 583 | Phosphorylation | VLLSHMITFLNDKND HHHHHHHHHHCCCCC | 17.94 | 26270265 | |
| 614 | Phosphorylation | YVGWQSSSILKPLLQ HHCCCCHHHHHHHHH | 36.87 | 24719451 | |
| 673 | Phosphorylation | HPNLWIRYGAVGFIT CCCEEEECCCHHHHE | 10.58 | 19664994 | |
| 680 | Phosphorylation | YGAVGFITVVARQIS CCCHHHHEEEEECCC | 13.48 | - | |
| 698 | Phosphorylation | VYCKLMPYLDPYITQ HHHHHHHHCCCCCCC | 15.12 | 20071362 | |
| 713 | Ubiquitination | PIIQIERKLVLLSVL CHHHHHHHHHHHHHH | 30.11 | - | |
| 731 | Phosphorylation | VSRSIFDYALRSKDI CCHHHHHHHHHCCCH | 9.22 | 28152594 | |
| 736 | Ubiquitination | FDYALRSKDITSLFR HHHHHHCCCHHHHHH | 46.87 | - | |
| 740 | Phosphorylation | LRSKDITSLFRHLHM HHCCCHHHHHHHHHH | 26.33 | 24719451 | |
| 772 | Ubiquitination | PAIAQLLKKLLSQGM HHHHHHHHHHHHCCC | 50.39 | 22817900 | |
| 773 | Malonylation | AIAQLLKKLLSQGMT HHHHHHHHHHHCCCC | 55.41 | 26320211 | |
| 773 | Ubiquitination | AIAQLLKKLLSQGMT HHHHHHHHHHHCCCC | 55.41 | 21906983 | |
| 776 | Phosphorylation | QLLKKLLSQGMTEEE HHHHHHHHCCCCHHH | 34.81 | 23401153 | |
| 780 | Phosphorylation | KLLSQGMTEEEEDKL HHHHCCCCHHHHHHH | 47.25 | - | |
| 786 | Ubiquitination | MTEEEEDKLLALKDF CCHHHHHHHHHHHHH | 48.99 | 22817900 | |
| 791 | Ubiquitination | EDKLLALKDFMMKSN HHHHHHHHHHHHHCC | 43.23 | 21906983 | |
| 796 | Ubiquitination | ALKDFMMKSNKAKAN HHHHHHHHCCHHHCC | 38.80 | 22817900 | |
| 797 | Phosphorylation | LKDFMMKSNKAKANI HHHHHHHCCHHHCCC | 26.18 | 29255136 | |
| 801 | Ubiquitination | MMKSNKAKANIVDQS HHHCCHHHCCCCCHH | 43.50 | 29967540 | |
| 808 | Phosphorylation | KANIVDQSHLHDSSQ HCCCCCHHHCCCCCC | 24.45 | 30266825 | |
| 813 | Phosphorylation | DQSHLHDSSQKGVID CHHHCCCCCCCCCCH | 24.74 | 30266825 | |
| 814 | Phosphorylation | QSHLHDSSQKGVIDL HHHCCCCCCCCCCHH | 41.80 | 30266825 | |
| 816 | Acetylation | HLHDSSQKGVIDLAA HCCCCCCCCCCHHHH | 58.03 | 25953088 | |
| 816 | Ubiquitination | HLHDSSQKGVIDLAA HCCCCCCCCCCHHHH | 58.03 | 29967540 | |
| 835 | Ubiquitination | GRQVDLVKTKQEPDD CCEEEEEECCCCCCH | 58.25 | 27667366 | |
| 836 | Phosphorylation | RQVDLVKTKQEPDDK CEEEEEECCCCCCHH | 30.40 | 28857561 | |
| 837 | Ubiquitination | QVDLVKTKQEPDDKR EEEEEECCCCCCHHH | 47.12 | 24816145 | |
| 843 | Acetylation | TKQEPDDKRARKHVK CCCCCCHHHHHHHHH | 56.17 | 26051181 | |
| 847 | Ubiquitination | PDDKRARKHVKQDSN CCHHHHHHHHHCCCC | 52.33 | 22817900 | |
| 850 | Ubiquitination | KRARKHVKQDSNVNE HHHHHHHHCCCCCCH | 48.37 | 21906983 | |
| 853 | Phosphorylation | RKHVKQDSNVNEEWK HHHHHCCCCCCHHHH | 39.94 | 22167270 | |
| 861 | Phosphorylation | NVNEEWKSMFGSLDP CCCHHHHHHHCCCCC | 22.03 | 21082442 | |
| 865 | Phosphorylation | EWKSMFGSLDPPNMP HHHHHHCCCCCCCCC | 20.52 | 25159151 | |
| 886 | Phosphorylation | SDQEVIQTGKPPRSE CCHHHHHCCCCCCCC | 35.73 | 26074081 | |
| 888 | Ubiquitination | QEVIQTGKPPRSESS HHHHHCCCCCCCCCC | 56.06 | 21906983 | |
| 892 | Phosphorylation | QTGKPPRSESSAGIC HCCCCCCCCCCCCEE | 47.83 | 30278072 | |
| 894 | Phosphorylation | GKPPRSESSAGICVP CCCCCCCCCCCEEEE | 27.08 | 30278072 | |
| 895 | Phosphorylation | KPPRSESSAGICVPL CCCCCCCCCCEEEEC | 26.85 | 30576142 | |
| 903 | Phosphorylation | AGICVPLSTSSQVPE CCEEEECCCCCCCCC | 21.85 | 26074081 | |
| 904 | Phosphorylation | GICVPLSTSSQVPEV CEEEECCCCCCCCCE | 39.83 | 26074081 | |
| 905 | Phosphorylation | ICVPLSTSSQVPEVT EEEECCCCCCCCCEE | 18.52 | 26074081 | |
| 906 | Phosphorylation | CVPLSTSSQVPEVTT EEECCCCCCCCCEEE | 34.97 | 26074081 | |
| 912 | Phosphorylation | SSQVPEVTTVQNKKP CCCCCCEEEECCCCC | 21.42 | 20068231 | |
| 913 | Phosphorylation | SQVPEVTTVQNKKPV CCCCCEEEECCCCCC | 25.85 | 20068231 | |
| 918 | Ubiquitination | VTTVQNKKPVIPVLS EEEECCCCCCEEEEC | 52.66 | - | |
| 925 | Phosphorylation | KPVIPVLSSTILPST CCCEEEECCCCCCCC | 26.18 | 30266825 | |
| 926 | Phosphorylation | PVIPVLSSTILPSTY CCEEEECCCCCCCCE | 18.46 | 30266825 | |
| 927 | Phosphorylation | VIPVLSSTILPSTYQ CEEEECCCCCCCCEE | 24.13 | 30266825 | |
| 931 | Phosphorylation | LSSTILPSTYQIRIT ECCCCCCCCEEEEEE | 35.98 | 20068231 | |
| 932 | Phosphorylation | SSTILPSTYQIRITT CCCCCCCCEEEEEEE | 19.94 | 27251275 | |
| 933 | Phosphorylation | STILPSTYQIRITTC CCCCCCCEEEEEEEC | 13.28 | 27642862 | |
| 938 | Phosphorylation | STYQIRITTCKTELQ CCEEEEEEECHHHHH | 19.12 | 20068231 | |
| 939 | Phosphorylation | TYQIRITTCKTELQQ CEEEEEEECHHHHHH | 15.05 | 20068231 | |
| 941 | Ubiquitination | QIRITTCKTELQQLI EEEEEECHHHHHHHH | 42.83 | - | |
| 942 | Phosphorylation | IRITTCKTELQQLIQ EEEEECHHHHHHHHH | 44.04 | - | |
| 951 | Acetylation | LQQLIQQKREQCNAE HHHHHHHHHHHHCHH | 41.34 | 25953088 | |
| 951 | Malonylation | LQQLIQQKREQCNAE HHHHHHHHHHHHCHH | 41.34 | 26320211 | |
| 951 | Ubiquitination | LQQLIQQKREQCNAE HHHHHHHHHHHHCHH | 41.34 | 22817900 | |
| 962 | Ubiquitination | CNAERIAKQMMENAE HCHHHHHHHHHHHCC | 36.03 | 29967540 | |
| 973 | Ubiquitination | ENAEWESKPPPPGWR HHCCCCCCCCCCCCC | 50.45 | 29967540 | |
| 993 | Ubiquitination | VAHLHEHKSAVNRIR EEEHHHCCCHHCEEE | 36.81 | 29967540 | |
| 1018 | Ubiquitination | CSNDGTVKIWNSQKM ECCCCCEEEEECCCC | 41.67 | 29967540 | |
| 1024 | Acetylation | VKIWNSQKMEGKTTT EEEEECCCCCCCCCC | 38.45 | 26051181 | |
| 1034 | Phosphorylation | GKTTTTRSILTYSRI CCCCCCHHHHEEEEE | 21.62 | 20068231 | |
| 1037 | Phosphorylation | TTTRSILTYSRIGGR CCCHHHHEEEEECCE | 20.13 | 20068231 | |
| 1038 | Phosphorylation | TTRSILTYSRIGGRV CCHHHHEEEEECCEE | 7.78 | 20068231 | |
| 1039 | Phosphorylation | TRSILTYSRIGGRVK CHHHHEEEEECCEEE | 16.52 | 20068231 | |
| 1074 | Phosphorylation | QLLGIEASKLPKSPK EEEEEEHHHCCCCCC | 23.18 | - | |
| 1079 | Phosphorylation | EASKLPKSPKIHPLQ EHHHCCCCCCCCCCH | 29.50 | 19369195 | |
| 1081 | Ubiquitination | SKLPKSPKIHPLQSR HHCCCCCCCCCCHHH | 61.82 | 29967540 | |
| 1272 | Phosphorylation | IRFWDLAYPERSYVV EEEEECCCCCCEEEE | 16.96 | - | |
| 1276 | Phosphorylation | DLAYPERSYVVAGST ECCCCCCEEEEECCC | 22.18 | 23663014 | |
| 1277 | Phosphorylation | LAYPERSYVVAGSTS CCCCCCEEEEECCCC | 12.74 | 23663014 | |
| 1282 | Phosphorylation | RSYVVAGSTSSPSVS CEEEEECCCCCCCHH | 18.51 | 23663014 | |
| 1283 | Phosphorylation | SYVVAGSTSSPSVSY EEEEECCCCCCCHHH | 32.10 | 23663014 | |
| 1284 | Phosphorylation | YVVAGSTSSPSVSYY EEEECCCCCCCHHHH | 41.78 | 23663014 | |
| 1285 | Phosphorylation | VVAGSTSSPSVSYYR EEECCCCCCCHHHHH | 22.68 | 23663014 | |
| 1287 | Phosphorylation | AGSTSSPSVSYYRKI ECCCCCCCHHHHHHH | 26.16 | 23663014 | |
| 1289 | Phosphorylation | STSSPSVSYYRKIIE CCCCCCHHHHHHHHC | 22.30 | 23663014 | |
| 1290 | Phosphorylation | TSSPSVSYYRKIIEG CCCCCHHHHHHHHCC | 12.72 | 23663014 | |
| 1291 | Phosphorylation | SSPSVSYYRKIIEGT CCCCHHHHHHHHCCC | 9.64 | 23663014 | |
| 1293 | Ubiquitination | PSVSYYRKIIEGTEV CCHHHHHHHHCCCHH | 31.73 | 22817900 | |
| 1307 | Ubiquitination | VVQEIQNKQKVGPSD HHHHHHHCCCCCCCC | 34.81 | 21906983 | |
| 1309 | Ubiquitination | QEIQNKQKVGPSDDT HHHHHCCCCCCCCCC | 51.25 | 22817900 | |
| 1316 | Phosphorylation | KVGPSDDTPRRGPES CCCCCCCCCCCCCCC | 24.56 | 21082442 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PI3R4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PI3R4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PI3R4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of PI3R4_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Myristoylation | |
| Reference | PubMed |
| "Characterization of p150, an adaptor protein for the humanphosphatidylinositol (PtdIns) 3-kinase. Substrate presentation byphosphatidylinositol transfer protein to the p150.PtdIns 3-kinasecomplex."; Panaretou C., Domin J., Cockcroft S., Waterfield M.D.; J. Biol. Chem. 272:2477-2485(1997). Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 53-63; 333-343;540-554 AND 786-791, MYRISTOYLATION AT GLY-2, PHOSPHORYLATION,COFACTOR, TISSUE SPECIFICITY, AND INTERACTION WITH PIK3C3. | |
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-808; SER-813; SER-814;SER-853; SER-861; SER-865; SER-892; SER-925 AND SER-1079, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-853; SER-865 ANDTHR-1316, AND MASS SPECTROMETRY. | |